Brief: Iovance Biotherapeutics Q4 Net Income USD -78.559 Million
27/02/2025 21:01
Feb 27 (Reuters) - Iovance Biotherapeutics Q4 operating income USD -86.576 million. Q4 pretax profit USD -77.001 million
Recent news on Iovance Biotherapeutics
See all newsBrief: Iovance Biotherapeutics Reports Inducement Grants
US RESEARCH ROUNDUP-BlackRock, Evercore, Goldman Sachs
Brief: Iovance Biotherapeutics Appoints Noah Berkowitz, M.D., Ph.D., As Chief Medical Officer
Iovance hits two-year high after raising annual revenue forecast
U.S. RESEARCH ROUNDUP- Berkshire Hathaway, Exxon Mobil, Honeywell Technologies